Skip to search formSkip to main contentSkip to account menu

autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine

Known as: autologous EBV-transformed B-lymphoblastoid cell vaccine 
A cell-based vaccine composed of autologous lymphoblastoid B cells activated against Epstein-Barr virus (EBV) in vitro with potential… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Human pro-urokinase (pro-UK) gene was engineered for expression in mammalian cells. The stability of recombinant pro-UKs produced… 
1995
1995
X-linked severe combined immunodeficiency (XSCID) is characterized by absent or profoundly reduced numbers of T cells and normal… 
1992
1992
Injection of Epstein-Barr virus (EBV)-transformed human lymphoblastoid B cells into immunodeficient SCID mice results in the… 
1986
1986
Lymphoblastoid B cells, spontaneously secreting specific antibodies of IgG and IgA classes, are constantly detected after in-vivo… 
1985
1985
Patients with T gamma lymphocytosis are a heterogeneous group, clearly distinguishable from other patients with chronic T… 
1984
1984
In vivo immunization of normal volunteers with tetanus toxoid induces the formation of a circulating B cell subset that has the… 
1983
Highly Cited
1980
Highly Cited
1980
A hybridoma has been isolated from the products of fusion of a myeloma cell line with spleen cells from mice immunized with a… 
1977
1977
The majority of human lymphocytic and myelocytic leukemia cells express a polymorphic antigen that is found on peripheral blood B…